QuidelOrtho
QDEL
$35.35
Share price
-3.18%
Change (1 day)
-25.53%
Change (1 year)
Quidel is an American manufacturer of diagnostics testings that can be used to diagnose infectious diseases as well as cardiovascular and metabolic diseases.
QuidelOrtho (QDEL) Fails to deliver data
Key failure to deliver metrics for QuidelOrtho:
- Last SEC data release: 2025-02-28
- Last 15 days FTD volume: $1.16 M
- Last 3 months FTD volume: $13.56 M
- Last year FTD volume: $13.56 M
A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.
Failures to deliver for QuidelOrtho (QDEL) - 3 months history
Number of shares, 3 months chart
Biweekly Failures to deliver volume for QuidelOrtho (QDEL) - since 2022
Volume in USD (price x number of shares), data since 2022QuidelOrtho (QDEL) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2025 | $7.28 M | -67.52% |
| 2024 | $22.43 M | -65.65% |
| 2023 | $65.3 M | 6.06% |
| 2022 | $61.56 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3 months) | FTD volume (1 year) | Country |
|---|---|---|---|
 | N/A | $0.11 M | 🇺🇸 USA |
 | $14.79 M | $76.13 M | 🇺🇸 USA |
 | $18.62 M | $0.17 B | 🇺🇸 USA |
 | $2.97 M | $3.79 M | 🇺🇸 USA |
 | $17.11 M | $0.21 B | 🇺🇸 USA |
 | $10.73 M | $58.8 M | 🇺🇸 USA |